|
ZNF564 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8645999999567E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57219999999503E-06 |
| Normal-vs-Stage2 |
3.295900E-03 |
| Normal-vs-Stage3 |
7.93669999999969E-05 |
| Normal-vs-Stage4 |
8.02269999988781E-07 |
| Stage1-vs-Stage2 |
8.734000E-01 |
| Stage1-vs-Stage3 |
1.172830E-01 |
| Stage1-vs-Stage4 |
7.215100E-03 |
| Stage2-vs-Stage3 |
2.314400E-01 |
| Stage2-vs-Stage4 |
3.953500E-02 |
| Stage3-vs-Stage4 |
3.699800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67717999999262E-05 |
| Normal-vs-AfricanAmerican |
1.367000E-04 |
| Normal-vs-Asian |
1.57355000000026E-05 |
| Caucasian-vs-AfricanAmerican |
7.193800E-01 |
| Caucasian-vs-Asian |
4.213600E-02 |
| AfricanAmerican-vs-Asian |
1.430210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.62070000045922E-07 |
| Normal-vs-Female |
1.263050E-03 |
| Male-vs-Female |
1.413230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.809900E-04 |
| Normal-vs-Extreme_Weight |
1.53915999999699E-05 |
| Normal-vs-Obese |
2.601800E-04 |
| Normal-vs-Extreme_Obese |
9.404000E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.531800E-01 |
| Normal_Weight-vs-Obese |
6.057000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.291800E-01 |
| Extreme_Weight-vs-Obese |
2.561000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.061800E-01 |
| Obese-vs-Extreme_Obese |
4.719400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.425300E-04 |
| Normal-vs-Age(41-60Yrs) |
5.954800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.55329999995679E-06 |
| Normal-vs-Age(81-100Yrs) |
3.039300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.629040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.634800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.773000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.686390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.488000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.231850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.174300E-04 |
| Normal-VS-Type2 PRCC |
1.27139999994696E-06 |
| Normal-VS-KIRP CIMP |
7.7886000000027E-05 |
| Normal-VS-Unclassified PRCC |
4.099400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.752000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.197750E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.332600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.565700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.319020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.197700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38899999996478E-06 |
| Normal-vs-N1 |
9.403800E-04 |
| Normal-vs-N2 |
2.122300E-03 |
| N0-vs-N1 |
6.719200E-01 |
| N0-vs-N2 |
3.021700E-02 |
| N1-vs-N2 |
1.096840E-01 |
|
|
